Home/Filings/4/0001209191-18-059344
4//SEC Filing

Growth Equity Opportunities IV, LLC 4

Accession 0001209191-18-059344

CIK 0001325879other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 7:39 PM ET

Size

15.0 KB

Accession

0001209191-18-059344

Insider Transaction Report

Form 4
Period: 2018-11-15
Transactions
  • Purchase

    Common Stock

    2018-11-15$1.86/sh+340,000$631,95819,038,038 total
  • Purchase

    Common Stock

    2018-11-19$1.88/sh+510,000$956,65819,898,038 total
  • Purchase

    Common Stock

    2018-11-16$1.86/sh+350,000$649,35519,388,038 total
Transactions
  • Purchase

    Common Stock

    2018-11-19$1.88/sh+510,000$956,65819,898,038 total
  • Purchase

    Common Stock

    2018-11-15$1.86/sh+340,000$631,95819,038,038 total
  • Purchase

    Common Stock

    2018-11-16$1.86/sh+350,000$649,35519,388,038 total
Transactions
  • Purchase

    Common Stock

    2018-11-19$1.88/sh+510,000$956,65819,898,038 total
  • Purchase

    Common Stock

    2018-11-16$1.86/sh+350,000$649,35519,388,038 total
  • Purchase

    Common Stock

    2018-11-15$1.86/sh+340,000$631,95819,038,038 total
Transactions
  • Purchase

    Common Stock

    2018-11-15$1.86/sh+340,000$631,95819,038,038 total
  • Purchase

    Common Stock

    2018-11-19$1.88/sh+510,000$956,65819,898,038 total
  • Purchase

    Common Stock

    2018-11-16$1.86/sh+350,000$649,35519,388,038 total
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.83 to $1.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
  • [F2]The shares are directly held by Growth Equity Opportunities Fund IV, LLC ("GEO IV") and indirectly held by New Enterprise Associates 15, L.P. ("NEA 15"), the sole member of GEO IV, NEA Partners 15, L.P. ("NEA Partners 15"), the sole general partner of NEA 15, NEA 15 GP, LLC ("NEA 15 GP"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA 15, NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP, together, the "Indirect Reporting Persons").
  • [F3]The individual managers of NEA 15 GP are Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, David M. Mott, Scott D. Sandell and Peter W. Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by GEO IV in which the Indirect Reporting Persons have no pecuniary interest.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.77 to $1.915, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.84 to $1.905, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (5) to this Form 4.

Issuer

AVEO PHARMACEUTICALS INC

CIK 0001325879

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001644965

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 7:39 PM ET
Size
15.0 KB